About Us

  1. Home
  2. About Us
Happy Customer
0 %

ABOUT US

Pioneering Pharmaceutical Excellence in Sri Lanka

Established in the year 2020, Cliniqon Biotech is breaking new grounds in the pharmaceutical industry in Sri Lanka envisioning to win the hearts of our stakeholder while focussing on how best the medical solutions can be used for the betterment of the public. Careful approaches are being taken to ensure maximum sustainability, in terms of suppliers and their standards and processes, thus safeguarding our strict measures of quality.

Cliniqon Biotech’s primary purpose is the importing and distributing of Medicine and related products that are of superior quality and ethical standards, and to pay special attention to availability and affordability of the medical services for the people who need them.

OUR APPROACH

Seamless and Reliable Solutions

Cliniqon Biotech’s primary purpose is importing and distributing medicines and related products of superior quality and ethical standards.

To be the preferred healthcare provider in Sri Lanka by delivering innovative, affordable, and high-quality pharmaceutical solutions with care and social responsibility.

To be the most admired pharmaceutical importer in Sri Lanka, trusted for our quality, reliability, and commitment to public health.

Cliniqon Biotech is driven by a commitment to transform healthcare through sustainable practices, innovation, and accountability. We focus on delivering not just medicines but solutions that enhance lives and foster trust.

MANAGEMENT TEAM

Meet the Experts

Our leadership team drives Cliniqon Biotech’s mission to deliver innovative, high-quality pharmaceutical solutions.

Ruwan Alokbandara

Deputy Chairman

Mr.Ruwan Alokbandara counts over 15 years of experience in Quality Assurance, Process excellence and system implementation in diverse fields including Garment Manufacturing, Telecommunication, Tea processing and service sector including BPO operation with ERP working environment. Prior to joining Cliniqon Biotech he served EAP Holding Limited as the Group Head of Quality Assurance.

He holds a diploma in Quality Assurance from Sri Lanka Standard Institution and a master’s Degree in Business Administration (MBA) from Mahatma Gandhi University, India.

In addition he serves as an assessor for Sri Lanka National Quality award and IRCA certified ISO 9001: 2008 lead auditor.

Malintha De Pinto

Managing Director

Mr. Malintha de Pinto, Managing Director at Cliniqon Biotech started as a student at St. Peter’s College, Colombo 04. Where he paved the stepping stones of a prodigious career.

His career spans over some of the most prestigious establishments in their respective industries.

12 years at Lifeline Pharmaceuticals (Pvt) Ltd as General Manager handling the entire Sales & Marketing Operation as well as 8 years at George Steuart Health as Trainee Medical Representative/Coordinator/Product Promotion Executive are his most valued career milestones. His stern attitude towards maximizing productivity within work parameters leads this fine organization towards success.

Chameen Aldeniya

Senior Director

Mr. Chameen Aldeniya, Senior Director at Cliniqon Biotech initiated his career as a student at Dharmaraja College, Kandy.

Afterwards the quality of professionalism performed at 12 years at Lifeline Pharmaceuticals (Pvt) Ltd as Assistant General Manager handling entire Branded Sales & Marketing Operations followed by 4 years at Emerchemie NB Ceylon Limited as Medical Representative/Coordinator as well as Previous to the above he also gained experience at Sunshine Healthcare Lanka Ltd and Gamma Pharmaceuticals are remarkable collective experience adding to the value pool he offers to this company.

His somewhat unorthodox approaches to problem solving is a pillar of strength and a great asset to this organization.

Vipula Dissanayake

Senior Director

Spearheading Cliniqon on a Directorial level, Mr. Vipula Srinath Dissanayake ascertains the growth of the company through critical and careful considerations to key areas such as Customer satisfaction in relation to quality products.

Starting his career in the pharmaceutical industry at young age as a Medical Representative in 1999, soon became Senior Sales Coordinating Executive in 2001 and continued for 14 years. In 2015, He served as a Senior Sales Manager in the Pharma Industry and also was employed as a Director in the export industry. He is a well-established Marketing expert in the field of pharmaceuticals rendering him to be the Director currently at Cliniqon since 2019.

Developing generic sales, Coordinating and Managing and Training, market research analyses are a few of the most valuable skills in his wheelhouse, making him a master of practical and approachable strategies. Mr Vipula’s vast experience adds value to our company as well as his ethical and practical approaches to strategic problem solving.

Harshani Jayakody

Deputy Director of Regulatory Affairs

Mrs. Harshani Jayakody has been the Deputy Director of Regulatory Affairs at Cliniqon Biotech (Pvt) Ltd since 2022. She possesses over two decades’ worth of expertise in pharmaceutical product regulations and guidelines liaising with officials from NMRA and NMQAL, ensuring compliance, quality, safety, and efficacy of pharmaceuticals.

Mrs. Jayakody collaborates with global manufacturers on medicines, medical devices, cosmetics, borderline products, and supplements. Her regulatory career began in 2003 as an Assistant Regulatory Affairs Officer at LifeServ’ (Private) Limited in Colombo. Steadily progressing over the next seven years until becoming the Manager of Regulatory Affairs at Lifeline Pharmaceuticals (Pvt) Ltd in 2010 and later serving as the Senior Manager at Eurochem Biotech.

Mrs. Jayakody also has valuable specialized training from ANB Laboratories in Thailand (2012), Pt. Otto Pharmaceuticals in Indonesia (2013), Theon Pharmaceuticals in India (2022), and VINPHACO in Vietnam (2023). Her versatile experiences and expertise underscore her commitment to ensuring compliance and facilitating global partnerships in the pharmaceutical industry.